🇺🇸 FDA
Patent

US 8119642

Structurally rigid dopamine D3 receptor selective ligands and process for making them

granted A61KA61K51/0459A61P

Quick answer

US patent 8119642 (Structurally rigid dopamine D3 receptor selective ligands and process for making them) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K51/0459, A61P, A61P25/36